Large Cap High Growth Potential

Results

256

7 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

256 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	AXSM	US$244.31	1.3%	127.3%	US$12.6b	US$276.47	17.8	57.4%	n/a	Pharmaceuticals & Biotech
	NVDA	US$195.60	0.3%	23.6%	US$4.7t	US$301.62	29.7	22.2%	0.5%	Semiconductors
	MOD	US$235.19	-8.3%	135.4%	US$12.2b	US$340.86	102.2	49.3%	n/a	Capital Goods
	GH	US$168.82	9.8%	240.8%	US$22.3b	US$150.88	20.7	58.2%	n/a	Healthcare
	LITE	US$731.25	-14.1%	702.9%	US$56.7b	US$1,111.29	129.6	79.1%	n/a	Tech
	MDGL	US$529.48	0.4%	83.1%	US$12.2b	US$678.71	10.8	59.2%	n/a	Pharmaceuticals & Biotech
	CRDO	US$265.55	8.1%	186.4%	US$45.1b	US$269.81	104.9	27.5%	n/a	Semiconductors
	BE	US$295.05	7.3%	1,111.2%	US$77.1b	US$282.49	13911.0	44.9%	n/a	Capital Goods
	AMD	US$552.05	2.3%	309.5%	US$844.4b	US$512.27	182.5	35.3%	n/a	Semiconductors
	NU	US$14.06	7.1%	5.2%	US$66.2b	US$17.82	5.4	20.2%	n/a	Banks
	MRVL	US$249.27	-10.3%	248.4%	US$214.6b	US$249.33	86.3	25.7%	0.1%	Semiconductors
	ARM	US$322.24	-6.2%	119.4%	US$336.7b	US$297.03	380.7	35.8%	n/a	Semiconductors
	SMTC	US$138.89	-11.0%	226.1%	US$12.6b	US$205.25	11.9	74.6%	n/a	Semiconductors
	LSCC	US$137.31	-6.5%	169.9%	US$18.7b	US$146.92	946.4	59.3%	n/a	Semiconductors
	CBRS	US$192.01	-11.2%	n/a	US$46.4b	US$291.09	445.0	73.7%	n/a	Semiconductors
	FN	US$500.75	-5.2%	74.7%	US$17.9b	US$749.11	42.6	23.3%	n/a	Tech
	MTSI	US$327.64	-12.1%	137.4%	US$24.6b	US$403.00	141.4	39.3%	n/a	Semiconductors
	RDDT	US$200.86	15.2%	31.0%	US$37.5b	US$224.92	54.7	25.3%	n/a	Media
	AXON	US$622.20	21.9%	-22.4%	US$48.1b	US$670.37	243.5	32.8%	n/a	Capital Goods
	AVGO	US$373.90	0.4%	36.4%	US$1.7t	US$523.73	60.7	33.5%	0.7%	Semiconductors
	APP	US$543.79	9.0%	57.6%	US$177.1b	US$654.47	46.7	21.8%	n/a	Software
	ALAB	US$432.74	-5.1%	382.9%	US$69.7b	US$272.47	277.2	30.9%	n/a	Semiconductors
	SITM	US$601.66	-15.3%	196.5%	US$15.9b	US$837.50	41.8	83.6%	n/a	Semiconductors
	KRYS	US$374.68	-0.9%	168.1%	US$11.1b	US$349.78	49.1	36.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 8